GLP-1 Human ELISA (Multispecies specificity)
| Other names: | GLP-1 | ||
|---|---|---|---|
| Cat. No.: | RSCYK160R | Regulatory status: RUO | |
| Size: | 96 wells (1 kit) | | | |
| Files: | Datasheet PDF (RUO) MSDS (RUO) | ||
| Legend: |  new product discount |
 temporarily out of stock order in advance |
|
Research topic
Animal studies, Diabetology
Storage/Shipping
+4°C/ Wet ice
Summary
GLP-1 is a peptide hormone from the intestinal mucosa, which is produced from its precursor, proglucagon by post transnational processing. GLP-1 may play a role in the physiological control of feeding. GLP-1 amide was supposed to improved glycemic control in patients with type 2 diabetes by increasing insulin secretion, by inhibiting glucagon secretion and by delaying gastric emptying rather than by altering extrapancreatic glucose metabolism. Intravenous GLP-1 and amide could normalize fasting hyperglycaemia in type 2 diabetic patients. Hyperglycaemia during parenteral nutrition could be controlled by exogenous GLP-1, whereas the chronic therapy of type 2 diabetes required GLP-1 derivatives with longer duration of action.
Assay format
Competitive ELISA, Immobilized antibody
Sample requirements
30 µl/well
Applications
Plasma
Calibration Curve
|
Calibration range
0.206 to 50 ng/ml
Shopping cart
Your cart is empty.